Reports Q1 product revenue $3.3M vs. $1M last year. Reports Q1 license revenue $3M vs. $0 last year. “This quarter marks the next step forward ...

Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenu ...

NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...

By now, many have seen the commercials with NBA legend Kareem Abdul-Jabbar explaining the importance of seeing ...

Triple T offers a faster, safer alternative to surgery, by selectively destroying the small adrenal nodule without removing the adrenal gland.

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...

A revolutionary minimally invasive treatment Triple T offers new hope for primary aldosteronism patients potentially replacing surgery with a faster safer alternative ...

The capital will support the company’s expansion and introduction of new regenerative medicine treatments. Nivaan Care plans ...

When Van Zandt VA Medical Center spokesman John Harlow first thought of applying for health care services through the VA, he hesitated, not wanting to take for himself assistance that other veterans ...